{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:13:32Z","timestamp":1773778412495,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.humpath.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T11:01:47Z","timestamp":1628766107000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas"],"prefix":"10.1016","volume":"117","author":[{"given":"Sindhu","family":"Shetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4647-3463","authenticated-orcid":false,"given":"Omar","family":"Habeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-5965","authenticated-orcid":false,"given":"Christine","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Astbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-7272","authenticated-orcid":false,"given":"Christopher","family":"Przybycin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S.","family":"Joehlin-Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.08.001_bib1","first-page":"921","article-title":"Relative frequency of primary ovarian neoplasms: a 10-year review","volume":"74","author":"Koonings","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2021.08.001_bib2","first-page":"56","article-title":"Borderline and malignant Brenner tumours of the ovary","volume":"80","author":"Hallgrimsson","year":"1972","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.humpath.2021.08.001_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/1097-0142(197207)30:1<174::AID-CNCR2820300125>3.0.CO;2-D","article-title":"Proliferative and malignant Brenner tumors of the ovary","volume":"30","author":"Miles","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.08.001_bib4","series-title":"WHO classification of tumours, female genital tumours","first-page":"73","article-title":"Tumours of the ovary","author":"Cheung","year":"2020"},{"key":"10.1016\/j.humpath.2021.08.001_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"MDM2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.08.001_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation","volume":"69","author":"Momand","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2021.08.001_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by MDM2","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.08.001_bib8","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1128\/MCB.18.12.7288","article-title":"Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6","volume":"18","author":"Freedman","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2021.08.001_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s000180050273","article-title":"Functions of the MDM2 oncoprotein","volume":"55","author":"Freedman","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2021.08.001_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","article-title":"Amplification of a gene encoding a p53-associated protein in human sarcomas","volume":"358","author":"Oilinger","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.08.001_bib11","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2021.08.001_bib12","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/bjc.1996.664","article-title":"DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours","volume":"74","author":"Courjal","year":"1996","journal-title":"Br J Canc"},{"key":"10.1016\/j.humpath.2021.08.001_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41379-020-00648-y","article-title":"Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma","volume":"34","author":"Chui","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<8::AID-PATH700>3.0.CO;2-#","article-title":"Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma","volume":"181","author":"Dei Tos","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/gcc.22480","article-title":"Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology","volume":"56","author":"Pfarr","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2021.08.001_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ajcp\/aqaa033","article-title":"Amplification of MDM2 and loss of p16 expression: do they have a role in malignant transformation of ovarian Brenner tumor? A morphologic and immunohistochemical study","volume":"154","author":"Wang","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2019.05.018","article-title":"The past, present and future of potential small-molecule drugs targeting p53-MDM2\/MDMX for cancer therapy","volume":"176","author":"Liu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.humpath.2021.08.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.humpath.2021.08.001_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/modpathol.2010.124","article-title":"Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics","volume":"23","author":"Yoshida","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/modpathol.2008.153","article-title":"Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma","volume":"22","author":"Weaver","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/PGP.0000000000000187","article-title":"Analysis of MDM2 amplification in 43 endometrial stromal tumors: a potential diagnostic pitfall","volume":"34","author":"Schoomeester","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib23","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/sj.onc.1205304","article-title":"Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer","volume":"21","author":"Simon","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2021.08.001_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder cancer","volume":"507","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.08.001_bib25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/01.pas.0000170343.09562.39","article-title":"MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data","volume":"29","author":"Binh","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jcp.2009.070201","article-title":"Can MDM2 and CDK4 make the diagnosis of well differentiated\/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours","volume":"62","author":"Aleixo","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13048-014-0101-7","article-title":"Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study","volume":"7","author":"De Cecio","year":"2014","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.humpath.2021.08.001_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01913120050132895","article-title":"Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder","volume":"24","author":"Ordonez","year":"2000","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/PGP.0b013e3182230e10","article-title":"Malignant Brenner tumor of the ovary with transformation to trabecular carcinoid: an immunocytochemical and electron microscopic study","volume":"31","author":"Roth","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/modpathol.2013.142","article-title":"The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis","volume":"27","author":"Kuhn","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e318188b84c","article-title":"Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas","volume":"33","author":"Cuatrecasas","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anndiagpath.2014.12.002","article-title":"Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor","volume":"19","author":"Roma","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2021.08.001_bib33","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1016\/j.ejca.2013.08.011","article-title":"Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium","volume":"49","author":"Kuhn","year":"2013","journal-title":"Eur J Canc"},{"key":"10.1016\/j.humpath.2021.08.001_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0b013e3181908e24","article-title":"Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations","volume":"33","author":"Esheba","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:36Z","timestamp":1758645516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"alternative-id":["S0046817721001416"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.08.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}